These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33075062)

  • 21. Molecular Surveillance of Drug Resistance of Plasmodium falciparum Isolates Imported from Angola in Henan Province, China.
    Zhou R; Yang C; Li S; Zhao Y; Liu Y; Qian D; Wang H; Lu D; Zhang H; Huang F
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of selection of antimalarial drug resistance markers after intermittent preventive treatment of schoolchildren (IPTsc) against malaria in northeastern Tanzania.
    Von Wowern F; Makenga G; Wellmann Thomsen S; Wellmann Thomsen L; Filtenborg Hocke E; Baraka V; Opot BH; Minja DTR; Lusingu JPA; Van-Geertruyden JP; Hansson H; Alifrangis M
    Int J Infect Dis; 2024 Sep; 146():107102. PubMed ID: 38876161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia.
    Rahmasari FV; Asih PBS; Rozi IE; Wangsamuda S; Risandi R; Dewayanti FK; Permana DH; Syahrani L; Prameswari HD; Basri HH; Bustos MDG; Charunwatthana P; Dondorp AM; Imwong M; Syafruddin D
    Malar J; 2023 Aug; 22(1):231. PubMed ID: 37553646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
    Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
    BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the
    Mungthin M; Watanatanasup E; Sitthichot N; Suwandittakul N; Khositnithikul R; Ward SA
    Am J Trop Med Hyg; 2017 Mar; 96(3):624-629. PubMed ID: 28044042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker.
    Leroy D; Macintyre F; Adoke Y; Ouoba S; Barry A; Mombo-Ngoma G; Ndong Ngomo JM; Varo R; Dossou Y; Tshefu AK; Duong TT; Phuc BQ; Laurijssens B; Klopper R; Khim N; Legrand E; Ménard D
    Malar J; 2019 Apr; 18(1):126. PubMed ID: 30967148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
    Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
    Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates.
    Foguim FT; Bogreau H; Gendrot M; Mosnier J; Fonta I; Benoit N; Amalvict R; Madamet M; Wein S; Pradines B;
    Malar J; 2020 Jun; 19(1):201. PubMed ID: 32503540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.
    Asua V; Vinden J; Conrad MD; Legac J; Kigozi SP; Kamya MR; Dorsey G; Nsobya SL; Rosenthal PJ
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
    van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
    Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis demonstrates high prevalence of chloroquine resistance but no evidence of artemisinin resistance in Plasmodium falciparum in the Chittagong Hill Tracts of Bangladesh.
    Alam MS; Ley B; Nima MK; Johora FT; Hossain ME; Thriemer K; Auburn S; Marfurt J; Price RN; Khan WA
    Malar J; 2017 Aug; 16(1):335. PubMed ID: 28806961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic association between the Pfk13 gene mutation and artemisinin resistance phenotype in Plasmodium falciparum isolates from Yunnan Province, China.
    Dong Y; Wang J; Sun A; Deng Y; Chen M; Xu Y; Xue J
    Malar J; 2018 Dec; 17(1):478. PubMed ID: 30563521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.
    Guerra M; Neres R; Salgueiro P; Mendes C; Ndong-Mabale N; Berzosa P; de Sousa B; Arez AP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of Plasmepsins 2 and 3 Sensitizes Plasmodium falciparum to the Antimalarial Drug Piperaquine.
    Mukherjee A; Gagnon D; Wirth DF; Richard D
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular surveillance of drug resistance: Plasmodium falciparum artemisinin resistance single nucleotide polymorphisms in Kelch protein propeller (K13) domain from Southern Pakistan.
    Ghanchi NK; Qurashi B; Raees H; Beg MA
    Malar J; 2021 Apr; 20(1):176. PubMed ID: 33827592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Antimalarial Efficacy of Dihydroartemisinin-Piperaquine on the China-Myanmar Border: The Calm Before the Storm.
    Fairhurst RM
    Am J Trop Med Hyg; 2015 Sep; 93(3):436-437. PubMed ID: 26283745
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya.
    Musyoka KB; Kiiru JN; Aluvaala E; Omondi P; Chege WK; Judah T; Kiboi D; Nganga JK; Kimani FT
    Infect Genet Evol; 2020 Mar; 78():104121. PubMed ID: 31756512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.
    Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE
    Malar J; 2015 Mar; 14():129. PubMed ID: 25890383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.